Tunisia is taking part in the second meeting of the leadership committee for the North African drug regulatory systems initiative, which is being held in Cairo on November 17-18, 2026. The country is represented by Somia Milad, the general director of the National Agency for Medicines and Health Products. This meeting follows the first meeting that took place in February 2025, where Tunisia was chosen to host the technical secretariat.

The North African drug regulatory systems initiative aims to enhance regional cooperation and harmonize legislative and regulatory frameworks for the pharmaceutical sector in North Africa. Tunisia's participation in this initiative reflects its commitment to supporting regional collaboration and ensuring access to safe and effective medicines. The initiative also seeks to promote regulatory integration, which will contribute to improved public health and strengthened pharmaceutical sovereignty in the region.

During the meeting, participants reviewed the progress of the initiative and examined the results of various working groups, focusing on areas such as inspection, pharmacovigilance, quality management systems, and information systems. They also approved strategic documents and discussed prospects for harmonizing regulatory procedures and practices for evaluating and registering medicines. This will help facilitate the registration and marketing of medicines across the region.

The initiative is a significant step towards enhancing regional integration in pharmaceutical regulation, which will support access to safe, effective, and high-quality medicines. It will also contribute to strengthening health security and promoting pharmaceutical sovereignty in North Africa. The meeting in Cairo brought together representatives from various countries in the region to discuss and implement a roadmap for achieving these objectives.

Tunisia's National Agency for Medicines and Health Products highlighted that the country has been entrusted with the secretariat of the initiative, reflecting its commitment to supporting regional cooperation. The agency emphasized that this role will enable Tunisia to promote harmonization of regulatory frameworks and enhance collaboration among North African countries.

The first meeting of the initiative, held in February 2025, resulted in the formation of a steering committee and the election of Egypt as the chair of the initiative for a three-year term. Morocco was chosen as the vice-chair, and Tunisia was designated as the host of the technical secretariat. The meeting also led to the adoption of a roadmap and reference terms of reference for the initiative.

The North African drug regulatory systems initiative is expected to have a positive impact on public health in the region by promoting access to safe and effective medicines. It will also help strengthen regulatory frameworks and enhance cooperation among countries in the region. Tunisia's participation in this initiative demonstrates its commitment to regional collaboration and its role in promoting health security in North Africa.

Key points

  • Tunisia participates in second meeting of North African drug regulatory systems initiative in Cairo
  • Initiative aims to enhance regional cooperation and harmonize legislative and regulatory frameworks for pharmaceutical sector
  • Tunisia hosts technical secretariat of initiative, promoting regional collaboration and health security

Reporting sources

Share this story

Written by

SaharaWire Newsroom
SaharaWire

Reporting for SaharaWire from the Nairobi bureau.